首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.
【24h】

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis.

机译:人原发性鳞状细胞癌中MiR-21过表达与患者预后不良有关。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

PURPOSE: This study compared miRNA expression patterns in primary squamous cell lung carcinoma specimens with those of matched normal lung tissue in order to determine their potential relevance to clinicopathological factors and patient postoperative survival times. METHODS: Locked nucleic acids miRNA microarray expression profiling was performed on four matched pairs of tissues. After microarray validation by quantitative real-time reverse transcription polymerase chain reaction assays (qRT-PCR) (real-time PCR), miR-21 was selected for further TaqMan real-time PCR study in 30 matched tissue pairs. RESULTS: Seven miRNAs of hsa-miR-21, hsa-miR-31, hsa-miR-34a, hsa-miR-22*, hsa-miR-504, hsa-miR-18a, and hsa-miR-412 were observed to be upregulated greater than twofold in the squamous cell lung carcinoma tissues compared with normal tissues, whereas 23 miRNAs of hsa-miR-30a, hsa-miR-30d, hsa-miR-126, hsa-miR-652, hsa-miR-100, hsa-miR-143, hsa-miR-130a, hsa-miR-145, hsa-miR-30e, hsa-miR-126*, hsa-miR-181a, hsa-miR-125b, hsa-miR-886-3p, hsa-miR-451, hsa-miR-29c, hsa-miR-26b, hsa-miR-101, hsa-miR-320, hsa-miR-30b, hsa-miR-886-5p, hsa-miR-29a, hsa-miR-26a, and hsa-miR-99a were found to be downregulated greater than twofold. MiR-21 was overexpressed in 73.3% of the squamous cell lung carcinoma specimens examined (P = 0.022). The relationship between the miR-21 expression level and various clinicopathologic factors was also analyzed. High-level expression of miR-21 was significantly correlated with shortened survival time (P = 0.022, log-rank test; Kaplan-Meier). Multivariate Cox proportional hazard regression analysis revealed this significant prognostic impact (P = 0.000; HR 1.293; 95% CI 1.123-1.489) to be independent of clinical disease stage (P = 0.013; HR 2.660; 95% CI 1.229-5.758) and other clinicopathologic factors. CONCLUSIONS: Expression patterns of miRNAs were found to be systematically altered in squamous cell lung carcinoma tissue. High miR-21 expression is associated with shortened survival time, indicating that miR-21 may serve as a molecular diagnostic and prognostic marker for patients with squamous cell lung carcinoma.
机译:目的:本研究比较了原发鳞状细胞肺癌标本和匹配的正常肺组织标本中的miRNA表达模式,以确定它们与临床病理因素和患者术后生存时间的潜在相关性。方法:在四对匹配的组织上进行了锁定的核酸miRNA微阵列表达分析。通过定量实时逆转录聚合酶链反应分析(qRT-PCR)(实时PCR)验证微阵列后,选择miR-21在30个匹配的组织对中进一步进行TaqMan实时PCR研究。结果:观察到七个hsa-miR-21,hsa-miR-31,hsa-miR-34a,hsa-miR-22 *,hsa-miR-504,hsa-miR-18a和hsa-miR-412的miRNA。与正常组织相比,在鳞状细胞肺癌组织中被上调了两倍以上,而hsa-miR-30a,hsa-miR-30d,hsa-miR-126,hsa-miR-652,hsa-miR- 100,hsa-miR-143,hsa-miR-130a,hsa-miR-145,hsa-miR-30e,hsa-miR-126 *,hsa-miR-181a,hsa-miR-125b,hsa-miR-886 -3p,hsa-miR-451,hsa-miR-29c,hsa-miR-26b,hsa-miR-101,hsa-miR-320,hsa-miR-30b,hsa-miR-886-5p,hsa-miR发现-29a,hsa-miR-26a和hsa-miR-99a被下调大于两倍。在所检查的鳞状细胞肺癌标本中,有73.3%的MiR-21过表达(P = 0.022)。还分析了miR-21表达水平与各种临床病理因素之间的关系。 miR-21的高水平表达与缩短的生存时间显着相关(P = 0.022,对数秩检验; Kaplan-Meier)。多元Cox比例风险回归分析显示,这种显着的预后影响(P = 0.000; HR 1.293; 95%CI 1.123-1.489)与临床疾病阶段无关(P = 0.013; HR 2.660; 95%CI 1.229-5.758)和其他临床病理因素。结论:发现miRNA在鳞状细胞肺癌组织中的表达模式发生了系统性改变。高表达的miR-21与缩短的生存时间有关,表明miR-21可以作为鳞状细胞肺癌患者的分子诊断和预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号